Patent ID: 6900218
Filing Date: 2005-05-31
Classification: A61K,A61P,C07C,C07D,C07K

Abstract:
1. The compound selected from: 3-(5-chloro-benzothiazol-2-ylsulfanyl)-2-hydroxyimino-propionic acid ethyl ester, 2-hydroxyimino-3-(5-methoxy-1H-benzoimidazol-2-ylsulfanyl)-propionic acid ethyl ester, and 3-(1H-benzoimidazol-2-ylsulfanyl)-2-hydroxyimino-propionic acid ethyl ester, or a single tautomer, single stereoisomer, a mixture of tautomers and/or stereoisomers, or a pharmaceutically acceptable salt thereof.